Get Cash Back and $0 Commissions + The Power of TradeStation
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of OPK, MCHP, ABBV, ALNY and CHGG
Globe Newswire 5-Nov-2018 12:52 PM
NEW YORK, Nov. 05, 2018 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.
OPKO Health Inc. (NASDAQ:OPK) Class Period: September 26, 2013 to September 7, 2018 Lead Plaintiff Deadline: November 13, 2018
Throughout the class period, OPKO Health Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) OPKO and its Chairman and Chief Executive Officer, Phillip Frost, were engaged in a pump-and-dump scheme with several other individuals and companies in their investments in several penny stocks; (2) this illicit scheme would result in governmental scrutiny including from the SEC; and (3) as a result, defendants' statements about OPKO's business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
Microchip Technology Inc. (NASDAQ:MCHP) Class Period: March 2, 2018 to August 9, 2018 Lead Plaintiff Deadline: November 16, 2018
The lawsuit alleges Microchip Technology Inc. made materially false and/or misleading statements and/or failed to disclose during the class period that: (1) Microsemi's financial performance was underperforming Microchip's expectations; and (2) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, including positive statements about Microsemi, were materially misleading and/or lacked a reasonable basis.
AbbVie Inc. (NYSE:ABBV) Class Period: October 25, 2013 to September 18, 2018 Lead Plaintiff Deadline: November 20, 2018
During the class period, AbbVie Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) AbbVie's strategy to increase the sales growth of its blockbuster drug, HUMIRA, relied in part upon illegal kickbacks and unlawful sales and marketing tactics; (2) such practices would foreseeably lead to heightened scrutiny by State governments and agencies; and (3) as a result, Defendants' public statements were materially false and misleading at all relevant times.
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Class Period: February 15, 2018 to September 12, 2018 Lead Plaintiff Deadline: November 26, 2018
The lawsuit alleges that Alnylam Pharmaceuticals, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) Alnylam overstated the efficacy and safety of its Onpattro (patisiran) lipid complex injection; and (2) as a result, Alnylam's public statements were materially false and misleading at all relevant times.
Chegg, Inc. (NYSE:CHGG) Class Period: July 30, 2018 to September 25, 2018 Lead Plaintiff Deadline: November 26, 2018
The complaint alleges that during the class period Chegg, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the Company lacked adequate security measures to protect users' data; (2) the Company lacked the internal controls and procedures to detect unauthorized access to its systems and to its data; (3) as a result, the Company would incur additional expenses and litigation risks; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis.
Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. There is no cost or obligation to you. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.
J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: J. Klein, Esq. Empire State Building 350 Fifth Avenue 59th Floor New York, NY 10118 jk@kleinstocklaw.com Telephone: (212) 616-4899 Fax: (347) 558-9665 www.kleinstocklaw.com
